Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Boehringer Ingelheim Animal Health's NexGard antiparasitic chewable tablet for dogs has gained a supplemental approval from the US FDA for the prevention of a bacterial infection.
Animal Pharm is looking for new authors for its animal health industry reports team.
New research has outlined the potential of repurposing common veterinary antiparasiticides for the control of human vector-borne diseases.
Last year, TyraTech did the opposite of many companies and offloaded its human health business. Now with a focus on animal health, the Morrisville, North Carolina-based firm can pursue a more disciplined growth strategy. Animal Pharm editor Joseph Harvey spoke to the company's chief executive Bruno Jactel.
Boehringer Ingelheim Animal Health has secured Japanese approval for Zactran (gamithromycin) as an antibiotic treatment of swine respiratory disease.
Bayer Animal Health has teamed up with Japanese firm Mitsui Chemicals Agro (MCAG) in its search for novel parasite prevention.
European regulatory authorities have recommended the refusal of a marketing authorization for Boehringer Ingelheim Animal Health's Longrange 50mg/ml.
Argentine business Brouwer is aiming to take its extensive portfolio to a wider global customer base.
MSD Animal Health has gained European approval for its Bravecto Plus antiparasitic for cats.
JA Saúde Animal has recently moved into the top 10 of Brazil's leading animal health companies, following heightened M&A activity in the country and its own organic growth.
US firm Neogen has added to its equine preventative range with the launch of a new fly protection product.
US parasite control company TyraTech has made progress in ramping up its product sales after it decided to focus solely on animal health.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.